Table 3.
Overview study self-report assessments.
| Construct | Questionnaire | T0 | T1 | T2 | T3 | T4 | T5 |
|---|---|---|---|---|---|---|---|
| Demographics | Socio-demographic data (SozDemo) | ✔ | – | – | – | – | – |
|
Psychopathology Mental health |
Mental health (PG) | ✔ | – | – | – | – | – |
| Psychopathology Depression |
Center for Epidemiological Studies Depression Scale - Short Version (CES-D)⁎ | ✔ | – | ✔ | ✔ | ✔ | ✔ |
| Psychopathology Anxiety |
General Anxiety Disorder Measurement (GAD-7) | ✔ | – | ✔ | ✔ | ✔ | ✔ |
| Psychopathology Depression |
Patient Health Questionnaire (PHQ-9) | – | ✔ | ✔ | ✔ | ✔ | ✔ |
| Psychopathology Alcohol abuse |
The Alcohol Use Disorders Identification Test (AUDIT-C) | – | ✔ | ✔ | ✔ | ✔ | ✔ |
|
Quality of life Wellbeing |
WHO-Five Wellbeing Index (WHO-5) | – | ✔ | – | ✔ | ✔ | ✔ |
| Quality of life | EuroQol (EQ-5D) | – | ✔ | – | ✔ | ✔ | ✔ |
| Quality of life | Assessment Quality of Life (AQoL-8D) | – | ✔ | – | ✔ | ✔ | ✔ |
| Quality of life Health economic evaluation |
Client Service Receipt Inventory (CSRI) | – | ✔ | – | – | ✔ | ✔ |
|
Training Expectancy |
Credibility/Expectancy Questionnaire (CEQ) | – | ✔ | – | – | – | – |
| Training Negative treatment effects |
Inventory to assess negative effects of psychotherapy (INEP) | – | – | – | ✔ | – | – |
| Training Program evaluation |
(Based on) Client Satisfaction Questionnaire (CSQ-8) | – | – | ✔ | ✔ | – | – |
| Training Attitudes toward help |
Attitudes Toward Seeking Professional Help (ATSPPHS)⁎ | – | ✔ | – | ✔ | – | – |
| Training Supportive accountability |
Supporting Accountability (SA) | – | – | ✔ | – | – | – |
| Training Treatment Satisfaction |
(adaption of) Working Alliance Inventory SR (WAI-SR) | – | – | ✔ | – | – | – |
|
Risk factors Risk factors questionnaire |
Risk Factor Questionnaire (developed by ICare Prevent team) (RF) | – | ✔ | – | – | – | – |
| Risk factor Worry |
Penn State Worry Questionnaire – Ultra Brief (PSWQ-3) | – | ✔ | – | ✔ | ✔ | ✔ |
| Risk factor Sleep |
Pittsburgh Sleep Quality Index (PSQI) | – | ✔ | – | ✔ | ✔ | ✔ |
| Risk factor Self-esteem |
Rosenberg Self Esteem Scale (RSES) | – | ✔ | ✔ | – | – | – |
| Risk factor Resilience |
Connor-Davidson Resilience Scale (CD-RISC) | – | ✔ | ✔ | ✔ | ✔ | ✔ |
|
Other Emotion regulation |
Subscales of emotion regulation scale questionnaire (SEK-15) | – | ✔ | – | ✔ | ✔ | ✔ |
| Other Incongruence |
Incongruence questionnaire (short version) (INK-K) | – | ✔ | ✔ | ✔ | ✔ | ✔ |
| Other Personality |
Big Five Inventory (BFI-10) | – | ✔ | – | – | – | – |
| Other Self-regulation |
Self-Regulation Scale (SSRQ)⁎ | – | ✔ | – | – | – | – |
| Other Behavioral activation |
The Behavioral Activation for Depression Scale (BADS-FS-9) | – | ✔ | – | ✔ | ✔ | ✔ |
| Other | Drop-Out Reasons (developed by ICare Prevent team) (DG) | – | – | – | ✔ | – | – |
| Other | Other help (developed by ICare Prevent team) (INH) | – | – | – | ✔ | – | – |
T0 = screening, T1 = baseline, T2 = 5 weeks after randomization, T3 = post-intervention, 8 weeks after randomization, T4 = 6-month follow-up, T5 = 12-month follow-up.
⁎
Trial site Netherlands will assess the CES-D only at screening and will not assess ATSPPHS, SSRQ and SEK, participation will be optional in the risk factor questionnaire.